RBA creates, negotiates and manages contracts on behalf of Biotech and Pharma companies that are initiating clinical trials and/or involved in the development of new drugs.With over seven years of industry specific experience and over a thousand successfully negotiated contracts, RBA has developed a unique, in-depth knowledge and familiarity with the relevant industry regulations, issues and developments.